A Randomized, Multicenter, Double-Blind Phase III Study of SAR439859 Plus Palbociclib Versus Letrozole Plus Palbociclib For the Treatment of Patients with ER +, HER2 - Breast Cancer Who Have Not Received Any Prior Systemic Anti-Cancer Treatment for Advanced Disease

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT04478266

Study #:
STUDY00146633

Start Date:
Jul 13, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04478266

View Complete Trial Details & Eligibility at ClinicalTrials.gov